// App-Quantinova.ai

2150 : Cangrelor: A New P2Y12 Inhibitor for Prevention of Shunt Thrombosis in Neonates with Congenital Heart Disease

Researchers

Presenter

  • Elisabeth Kaza

Principal Investigators

  • Hairu Zhou

  • Tamar Mendelsberg

  • Julie Vincent

  • Emile Bacha

  • Thomas Diacovo

Medical Centers

  • Surgery, Columbia University Medical Center (CUMC), NYC, NY

  • Surgery, Columbia University Medical Center (CUMC), NYC, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Congenital heart disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • cangrelor

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved